[{"address1": "201 Haskins Way", "address2": "Suite 230", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 407 2376", "website": "https://www.cero.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. Christopher B. Ehrlich M.B.A.", "age": 55, "title": "CEO & Chair", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1080000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew Albert Kucharchuk M.B.A.", "age": 44, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 252000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kristen  Pierce Ph.D.", "age": 55, "title": "Chief Development Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 360000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lawrence  Corey M.D.", "age": 78, "title": "Co-founder & Head of Scientific Advisory Board", "yearBorn": 1947, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.042, "open": 0.042, "dayLow": 0.042, "dayHigh": 0.0461, "regularMarketPreviousClose": 0.042, "regularMarketOpen": 0.042, "regularMarketDayLow": 0.042, "regularMarketDayHigh": 0.0461, "payoutRatio": 0.0, "beta": 0.296, "forwardPE": -0.01844, "volume": 20724, "regularMarketVolume": 20724, "averageVolume": 451831, "averageVolume10days": 585890, "averageDailyVolume10Day": 585890, "bid": 0.0461, "ask": 0.052, "bidSize": 63001, "askSize": 10000, "marketCap": 972833, "fiftyTwoWeekLow": 0.037, "fiftyTwoWeekHigh": 42.0, "allTimeHigh": 25600.0, "allTimeLow": 0.037, "fiftyDayAverage": 0.06794, "twoHundredDayAverage": 5.611315, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 8695108, "profitMargins": 0.0, "floatShares": 21069751, "sharesOutstanding": 21102671, "sharesShort": 192892, "sharesShortPriorMonth": 106183, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.1034, "heldPercentInsiders": 0.00153, "heldPercentInstitutions": 0.01039, "shortRatio": 0.83, "shortPercentOfFloat": 0.105, "impliedSharesOutstanding": 21102671, "bookValue": -8.849, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -49191016, "trailingEps": -3.21, "forwardEps": -2.5, "lastSplitFactor": "1:20", "lastSplitDate": 1749772800, "enterpriseToEbitda": -0.506, "52WeekChange": -0.99890625, "SandP52WeekChange": 0.120657206, "quoteType": "EQUITY", "currentPrice": 0.0461, "recommendationKey": "none", "totalCash": 1947316, "totalCashPerShare": 0.092, "ebitda": -17184494, "totalDebt": 931023, "quickRatio": 0.23, "currentRatio": 0.302, "returnOnAssets": -2.10219, "grossProfits": -500000, "freeCashflow": -7849772, "operatingCashflow": -13813913, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CERO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "shortName": "CERo Therapeutics Holdings, Inc", "longName": "CERo Therapeutics Holdings, Inc.", "fullExchangeName": "OTC Markets OTCQB", "averageDailyVolume3Month": 451831, "fiftyTwoWeekLowChange": 0.009100001, "fiftyTwoWeekLowChangePercent": 0.24594598, "fiftyTwoWeekRange": "0.037 - 42.0", "fiftyTwoWeekHighChange": -41.9539, "fiftyTwoWeekHighChangePercent": -0.9989024, "fiftyTwoWeekChangePercent": -99.890625, "epsTrailingTwelveMonths": -3.21, "epsForward": -2.5, "epsCurrentYear": -4.29, "priceEpsCurrentYear": -0.010745921, "fiftyDayAverageChange": -0.021839995, "fiftyDayAverageChangePercent": -0.32146004, "twoHundredDayAverageChange": -5.5652146, "twoHundredDayAverageChangePercent": -0.99178445, "priceToBook": -0.0052096285, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Phoenix Biotech Acquisition Corp.", "nameChangeDate": "2026-02-06", "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1770411520, "exchange": "OQB", "messageBoardId": "finmb_1673740339", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 9.76191, "regularMarketPrice": 0.0461, "marketState": "CLOSED", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1638282600000, "regularMarketChange": 0.0041000023, "regularMarketDayRange": "0.042 - 0.0461", "displayName": "CERo Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-02-07"}]